UY39584A - DERIVADOS DE IMIDAZO[1,2-a]PIRIDINILO Y SU USO EN EL TRATAMIENTO DE ENFERMEDADES - Google Patents
DERIVADOS DE IMIDAZO[1,2-a]PIRIDINILO Y SU USO EN EL TRATAMIENTO DE ENFERMEDADESInfo
- Publication number
- UY39584A UY39584A UY0001039584A UY39584A UY39584A UY 39584 A UY39584 A UY 39584A UY 0001039584 A UY0001039584 A UY 0001039584A UY 39584 A UY39584 A UY 39584A UY 39584 A UY39584 A UY 39584A
- Authority
- UY
- Uruguay
- Prior art keywords
- disease
- imidazo
- diseases
- treatment
- pyridinyl derivatives
- Prior art date
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 4
- 201000010099 disease Diseases 0.000 title abstract 3
- -1 IMIDAZO[1,2-a]PYRIDINYL Chemical class 0.000 title abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 208000020084 Bone disease Diseases 0.000 abstract 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 101000977771 Homo sapiens Interleukin-1 receptor-associated kinase 4 Proteins 0.000 abstract 1
- 102100023533 Interleukin-1 receptor-associated kinase 4 Human genes 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Esta divulgacion se relaciona con derivados de imidazo[1,2-a]piridinilo de formula (I), o sales farmacéuticamente aceptables de estos, donde todas las variables son como se definen en la memoria descriptiva, capaces de modular la actividad de IRAK4. La divulgación proporciona además métodos para su preparación, para su uso médico, en particular para su uso en el tratamiento y manejo de enfermedades o trastornos que incluyen enfermedad inflamatoria, enfermedad autoinmune, cáncer, enfermedad cardiovascular, una enfermedad del sistema nervioso central, enfermedad de la piel, una enfermedad y afección oftálmica y una enfermedad de los huesos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063128964P | 2020-12-22 | 2020-12-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY39584A true UY39584A (es) | 2022-07-29 |
Family
ID=80050991
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001039584A UY39584A (es) | 2020-12-22 | 2021-12-21 | DERIVADOS DE IMIDAZO[1,2-a]PIRIDINILO Y SU USO EN EL TRATAMIENTO DE ENFERMEDADES |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20240116922A1 (es) |
| EP (1) | EP4267576A1 (es) |
| JP (1) | JP2024501282A (es) |
| KR (1) | KR20230134500A (es) |
| CN (1) | CN116867781A (es) |
| AR (1) | AR124451A1 (es) |
| AU (1) | AU2021409546A1 (es) |
| CA (1) | CA3203129A1 (es) |
| CO (1) | CO2023009316A2 (es) |
| IL (1) | IL303966A (es) |
| MX (1) | MX2023007511A (es) |
| TW (1) | TW202332435A (es) |
| UY (1) | UY39584A (es) |
| WO (1) | WO2022140425A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY39844A (es) * | 2021-07-07 | 2023-01-31 | Biogen Ma Inc | Compuestos para la degradación selectiva de las proteínas irak4 |
| WO2023152349A1 (en) * | 2022-02-14 | 2023-08-17 | Astrazeneca Ab | Irak4 inhibitors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004078163A2 (en) | 2003-02-28 | 2004-09-16 | Transform Pharmaceuticals, Inc. | Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| WO2020150626A1 (en) | 2019-01-18 | 2020-07-23 | Biogen Ma Inc. | Imidazo[1,2-a]pyridinyl derivatives as irak4 inhibitors |
| MX2021015498A (es) * | 2019-06-27 | 2022-04-20 | Biogen Ma Inc | Derivados de imidazo[1,2-a]piridinilo y su uso en el tratamiento de enfermedades. |
| BR112021026369A2 (pt) * | 2019-06-27 | 2022-05-17 | Biogen Ma Inc | Derivados de 2h-indazol e seu uso no tratamento de doenças |
-
2021
- 2021-12-21 EP EP21848378.2A patent/EP4267576A1/en active Pending
- 2021-12-21 CN CN202180094021.2A patent/CN116867781A/zh active Pending
- 2021-12-21 KR KR1020237025045A patent/KR20230134500A/ko unknown
- 2021-12-21 US US18/269,073 patent/US20240116922A1/en active Pending
- 2021-12-21 TW TW110148009A patent/TW202332435A/zh unknown
- 2021-12-21 WO PCT/US2021/064666 patent/WO2022140425A1/en active Application Filing
- 2021-12-21 IL IL303966A patent/IL303966A/en unknown
- 2021-12-21 AU AU2021409546A patent/AU2021409546A1/en active Pending
- 2021-12-21 UY UY0001039584A patent/UY39584A/es unknown
- 2021-12-21 CA CA3203129A patent/CA3203129A1/en active Pending
- 2021-12-21 MX MX2023007511A patent/MX2023007511A/es unknown
- 2021-12-21 AR ARP210103599A patent/AR124451A1/es unknown
- 2021-12-21 JP JP2023538705A patent/JP2024501282A/ja active Pending
-
2023
- 2023-07-13 CO CONC2023/0009316A patent/CO2023009316A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW202332435A (zh) | 2023-08-16 |
| WO2022140425A1 (en) | 2022-06-30 |
| MX2023007511A (es) | 2023-09-08 |
| AR124451A1 (es) | 2023-03-29 |
| CO2023009316A2 (es) | 2023-09-29 |
| KR20230134500A (ko) | 2023-09-21 |
| US20240116922A1 (en) | 2024-04-11 |
| JP2024501282A (ja) | 2024-01-11 |
| CA3203129A1 (en) | 2022-06-30 |
| IL303966A (en) | 2023-08-01 |
| AU2021409546A1 (en) | 2023-07-06 |
| EP4267576A1 (en) | 2023-11-01 |
| CN116867781A (zh) | 2023-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2022000659A2 (es) | Derivados de imidazo[1,2-a]piridinilo y su uso en el tratamiento de enfermedades | |
| CO2023009316A2 (es) | Derivados de imidazo[1,2-a]piridinilo como inhibidores de irak4 y su uso en el tratamiento de enfermedades | |
| UY38765A (es) | Derivados de 2h-indazol y su uso en el tratamiento de enfermedades | |
| ECSP11011067A (es) | Compuestos para el tratamiento de enfermedades y desórdenes oftalmológicos | |
| UY27834A1 (es) | Compuestos de amidas de acido 3-amino-tieno(2,3-b) piiridino-2-carboxilico sustituido y procedimientos para prepararlos y sus usos. | |
| CL2011003346A1 (es) | Compuestos derivados de 2,3-dihidro-5h-[1,3]tiazolo[3,2-a]pirimidin-5-ona, moduladores de pi3k; composicion farmaceutica; y uso para tratar una enfermedad de base inmunologica, cancer o enfermedad pulmonar en un paciente. | |
| CU23208A3 (es) | Oxazolidinonas sustituidas y su uso en el campo de la coagulacion sanguinea | |
| HN2004000232A (es) | " derivados de pirrolo(3,4-c) pirazol activos como inhibidores de quinasa, proceso para su preparacion y composiciones farmaceuticas que los comprenden." | |
| CR8546A (es) | DERIVADOS DE 1H-TIENO [2,3c] PIRAZOL UTILES COMO INHIBIDORES DE QUINASA | |
| UY37379A (es) | Derivados de n-(piridin-2-il)piridina-sulfonamida y su uso en el tratamiento de enfermedades | |
| UY28837A1 (es) | Oxadiazolonas procedimientos para su preparación y su uso como productos farmacéuticos. | |
| UY29065A1 (es) | Derivados del ácido alcanoico arilcicloalquil-sustituidos, procedimientos para su preparación y su uso como productos farmacéuticos. | |
| CO2023009313A2 (es) | Derivados de 2h-indazol como inhibidores de irak4 y su uso en el tratamiento de enfermedades | |
| AR047005A1 (es) | Cuerpos de inclusion que transportan glicerol-fosfato aceptables para uso farmaceutico | |
| CO2023001509A2 (es) | Cepa c de prevotella histicola como terapia oral para enfermedades inflamatorias | |
| AR088845A1 (es) | Composiciones farmaceuticas que contienen 7-(1h-imidazol-4-ilmetil)-5,6,7,8-tetrahidro-quinolina para el tratamiento de las enfermedades y las afecciones de la piel | |
| ES2185837T3 (es) | Utilizacion de derivados de teofilina para el tratamiento y la profilaxis de las enfermedades de choque, nuevos compuestos de xantina y procedimientos para su produccion. | |
| PE20231562A1 (es) | DERIVADOS DE IMIDAZO[1,2-a]PIRIDINILO COMO INHIBIDORES DE IRAK4 Y SU USO EN EL TRATAMIENTO DE ENFERMEDADES | |
| UY29043A1 (es) | Derivados de diarilmetil piperazina, preparaciones de los mismos y usos de los mismos | |
| AR122609A1 (es) | Composiciones y métodos para el tratamiento de enfermedades y trastornos usando fournierella massiliensis | |
| AR122608A1 (es) | Composiciones y métodos para el tratamiento de enfermedades y trastornos usando harryflintia acetispora | |
| CO2020012484A2 (es) | Inhibidores de secreción de proteínas basados en triazaciclododecansulfonamida ("tcd") | |
| AR123017A1 (es) | Cepa c de prevotella histicola como terapia oral para enfermedades inflamatorias | |
| CU20060152A7 (es) | Derivados 1h-tieno[2,3-c]pirazol útiles como inhibidores de quinasa |